Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Dumas

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Journal of Medicinal Chemistry|October 7, 2011
Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperoneFrançois Vallée, Chantal Carrez, Fabienne Pilorge, et al.
ACS Chemical Biology|August 23, 2012
In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compoundThomas A Keating, Joseph V Newman, Nelson B Olivier, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituentUday R Khire, Donald Bankston, James Barbosa, et al.
Journal of Medicinal Chemistry|October 10, 2012
Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK)Gabriel Martínez-Botella, John N Breen, James E S Duffy, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitorJacques Dumas, Holia Hatoum-Mokdad, Robert N Sibley, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancerPhilip Wickens, Harold Kluender, Julie Dixon, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Journal of Medicinal Chemistry|October 7, 2011
Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperoneFrançois Vallée, Chantal Carrez, Fabienne Pilorge, et al.
ACS Chemical Biology|August 23, 2012
In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compoundThomas A Keating, Joseph V Newman, Nelson B Olivier, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors: SAR of the amide substituentUday R Khire, Donald Bankston, James Barbosa, et al.
Journal of Medicinal Chemistry|October 10, 2012
Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK)Gabriel Martínez-Botella, John N Breen, James E S Duffy, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Synthesis and pharmacological characterization of a potent, orally active p38 kinase inhibitorJacques Dumas, Holia Hatoum-Mokdad, Robert N Sibley, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancerPhilip Wickens, Harold Kluender, Julie Dixon, et al.
Pageof 3